Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Summit Therapeu ADR (SMMT)

11.68 -0.5 (-4.11%)

02-16 16:00

Open:

12.05

Pre. Close:

12.18

High:

12.35

Low:

11.58

Volume:

52,082

Market Cap:

164M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

12.36 - 12.422

12.422 - 12.462

Low:

11.437 - 11.516

11.516 - 11.567

Close:

11.566 - 11.686

11.686 - 11.763

Technical analysis  (as of: 2018-02-16 4:26:26 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 15.99     One year: 18.57

Support:

Support1: 10.11    Support2: 8.41

Resistance:

Resistance1: 13.69    Resistance2: 15.90

Pivot:

12.27

Moving Averages:

MA(5): 11.65     MA(20): 12.49

MA(100): 11.57     MA(250): 11.93

MACD:

MACD(12,26): -0.13     Signal(12,26,9):

%K %D:

%K(14,3): 35.21     %D(3): 30.48

RSI:

RSI(14): 46.97

52-Week:

High: 16.861  Low: 8.8  Change(%): -1.8

Average Vol(K):

3-Month: 7561  10-Days 7665

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
SMMT has closed above bottom band by 37.3%. Bollinger Bands are 70.6% wider than normal. The large width of the bands suggest high volatility as compared to SMMT's normal range. The bands have been in this wide range for 9 bars. This is a sign that the current trend might continue.

Headline News

Sun, 26 Jun 2016 16:52:53 GMT
Summit Therapeutics PLC ADR

Sun, 13 Feb 2011 09:40:58 GMT
News Summit Therapeutics PLC ADRSMMT

Tue, 04 Oct 2016 11:58:33 GMT
Summit Therapeutics stock surges 50% on news of licensing deal with Sarepta

Thu, 25 Jan 2018 15:56:15 GMT
Summit Therapeutics (SMMT) Stock: Gaining Big On Strong Clinical Results

Wed, 14 Feb 2018 15:56:15 GMT
BTIG Research Initiates Coverage on Summit Therapeutics (NASDAQ:SMMT). What ...

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

14.93

Shares Float (M)

14.93

% Held by Insiders

% Held by Institutions

91.00

Shares Short (K)

5

Shares Short Prior Month (K)

10

Stock Financials

EPS

-2.250

EPS Est. Current Year

-0.530

EPS Est. Next Year

-1.050

EPS Est. Next Quarter

-0.620

Forward EPS

-0.960

Book Value (p.s.)

34.760

PEG Ratio

Profit Margin

19.58

Operating Margin

-40.00

Return on Assets (ttm)

-4.0

Return on Equity (ttm)

-21.0

Qtrly Rev. Growth

199.8

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.397

Qtrly Earnings Growth

Operating Cash Flow (M)

-20.49

Levered Free Cash Flow (M)

-16.87

atoplab.com

Valuation

P/E

-5.19

P/E Growth Ratio

-0.04

P/BV

0.34

P/S

270521056.00

P/CF

-8.51

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.